Info
Insider Ownership

Insider Trading & Ownership of JAMES B. BREITMEYER

Summary: The estimated net worth of JAMES B. BREITMEYER is at least $325K dollars as of 15 Feb 2024. JAMES B. BREITMEYER is the Chief Executive Officer, Director of Oncternal Therapeutics, Inc. and owns shares of Oncternal Therapeutics, Inc. stock worth about $325K.
Signature: /s/Chase C. Leavitt, Attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when JAMES B. BREITMEYER files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of JAMES B. BREITMEYER

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ONCT	Oncternal Therapeutics, Inc.	Chief Executive Officer, Director	$325K			14 Feb 2024
OTIC	OTONOMY, INC.	Director				21 Jun 2022
ZGNX	ZOGENIX, INC.	Director				07 Mar 2022

Insider Transactions Reported by JAMES B. BREITMEYER:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.